$13.33
-0.02-0.15%
Last update: Nov 10, 4:26 PM
Latigo Biotherapeutics Inc
LTGONASDAQ
Latigo Biotherapeutics fell 27.0% from $18.25 to $13.33, behind the S&P 500's −3.0%. Its worst day was Sep 24 (−11.1%), and its low came Nov 6 at $12.60.
Aug 7, 2026 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Latigo Biotherapeutics closed at its highest level of the year, 37.0% above where the year started.
+3.6% · S&P 500 +0.7%
EPS of $-27.59 missed the $-0.46 estimate on $0.00 revenue.
Story events cover the past 12 months · Times ET
+2.5% · S&P 500 −0.4%
EPS of $-0.55 beat the $-0.67 estimate on $0.00 revenue.
−7.3% · S&P 500 −4.4%
Where it ended: a close of $13.33 on Nov 10, 2026. Up next: Q4 2026 earnings on Feb 19, 2027 (EPS est. $-0.45).
Nothing in the past 12 months.
All LTGO dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for LTGO and SPY from Benzinga historical bars. Not investment advice.
